STAT+: Pharmalittle: We’re watching a ban compounded versions of GLP-1s, a Biogen acquisition, and more
STAT
MAY 22, 2024
A drug often used off-label to treat alcohol use disorder might provide better benefits than therapies approved for this indication, STAT tells us. Australia to ban compounded versions of blockbuster drugs Ozempic and Mounjaro, Reuters reports. If you don’t believe me, just read these items.
Let's personalize your content